ANIP
ANI PHARMACEUTICALS INCCompany with tickers: ANIP
CIK
1023024
Shares Outstanding
22,414,104
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-13 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,162 |
| 2026-03-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 |
| 2026-03-11 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Sell | 4,772 |
| 2026-03-09 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,602 |
| 2026-03-09 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 5,087 |
| 2026-03-07 | Mutz Christopher | HEAD OF RARE DISEASE | Tax | 3,314 |
| 2026-03-07 | Lalwani Nikhil | Director, PRESIDENT & CEO | Tax | 17,060 |
| 2026-03-07 | Gutwerg Ori | SVP, GENERICS | Tax | 3,314 |
| 2026-03-07 | CAREY STEPHEN P. | SVP & CFO | Tax | 5,150 |
| 2026-03-06 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 2,121 |
| 2026-03-06 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,485 |
| 2026-03-05 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,312 |
| 2026-03-05 | CAREY STEPHEN P. | SVP & CFO | Convert | 3,312 |
| 2026-03-05 | CAREY STEPHEN P. | SVP & CFO | Convert | 3,312 |
| 2026-03-03 | Gutwerg Ori | SVP, GENERICS | Sell | 2,060 |
| 2026-03-03 | Walsh Patrick D | Director | Sell | 6,000 |
| 2026-03-02 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 417 |
| 2026-02-28 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Tax | 628 |
| 2026-02-28 | Mutz Christopher | HEAD OF RARE DISEASE | Tax | 2,221 |
| 2026-02-28 | Lalwani Nikhil | Director, PRESIDENT & CEO | Tax | 12,217 |
| 2026-02-28 | Gutwerg Ori | SVP, GENERICS | Tax | 2,221 |
| 2026-02-28 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Tax | 2,221 |
| 2026-02-28 | Davis Krista | SVP, CHIEF HR OFFICER | Tax | 1,555 |
| 2026-02-28 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Tax | 1,555 |
| 2026-02-28 | CAREY STEPHEN P. | SVP & CFO | Tax | 2,773 |
| 2026-02-26 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Award | 11,116 |
| 2026-02-26 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Other | 431,920 |
| 2026-02-26 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Award | 6,021 |
| 2026-02-26 | Mutz Christopher | HEAD OF RARE DISEASE | Award | 21,306 |
| 2026-02-26 | Lalwani Nikhil | Director, PRESIDENT & CEO | Award | 75,592 |
| 2026-02-26 | Gutwerg Ori | SVP, GENERICS | Award | 12,969 |
| 2026-02-26 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Award | 11,116 |
| 2026-02-26 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Other | 158,490 |
| 2026-02-26 | Davis Krista | SVP, CHIEF HR OFFICER | Award | 10,810 |
| 2026-02-26 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Award | 13,895 |
| 2026-02-26 | CAREY STEPHEN P. | SVP & CFO | Award | 22,233 |
| 2026-02-20 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 5,323 |
| 2026-02-20 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,730 |
| 2026-02-19 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 2,084 |
| 2026-02-14 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Tax | 1,779 |
| 2026-02-14 | CAREY STEPHEN P. | SVP & CFO | Tax | 2,448 |
| 2026-02-14 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Tax | 485 |
| 2026-02-14 | Mutz Christopher | HEAD OF RARE DISEASE | Tax | 2,403 |
| 2026-02-14 | Lalwani Nikhil | Director, PRESIDENT & CEO | Tax | 10,298 |
| 2026-02-14 | Gutwerg Ori | SVP, GENERICS | Tax | 1,888 |
| 2026-02-14 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Tax | 1,717 |
| 2026-02-14 | Davis Krista | SVP, CHIEF HR OFFICER | Tax | 1,290 |
| 2026-02-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 |
| 2026-02-12 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Tax | 1,534 |
| 2026-02-12 | CAREY STEPHEN P. | SVP & CFO | Tax | 2,829 |
| 2026-02-12 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Tax | 566 |
| 2026-02-12 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 7,032 |
| 2026-02-12 | Mutz Christopher | HEAD OF RARE DISEASE | Tax | 3,173 |
| 2026-02-12 | Lalwani Nikhil | Director, PRESIDENT & CEO | Tax | 11,688 |
| 2026-02-12 | Gutwerg Ori | SVP, GENERICS | Tax | 1,775 |
| 2026-02-12 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Other | 158,490 |
| 2026-02-12 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Tax | 1,608 |
| 2026-02-12 | Davis Krista | SVP, CHIEF HR OFFICER | Tax | 1,180 |
| 2026-02-11 | CAREY STEPHEN P. | SVP & CFO | Tax | 5,503 |
| 2026-02-11 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Tax | 3,011 |
| 2026-02-11 | Davis Krista | SVP, CHIEF HR OFFICER | Tax | 3,017 |
| 2026-02-11 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Other | 158,490 |
| 2026-02-11 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Tax | 4,269 |
| 2026-02-11 | Gutwerg Ori | SVP, GENERICS | Tax | 4,267 |
| 2026-02-11 | Lalwani Nikhil | Director, PRESIDENT & CEO | Tax | 30,659 |
| 2026-02-11 | Mutz Christopher | HEAD OF RARE DISEASE | Tax | 4,546 |
| 2026-02-11 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Tax | 1,762 |
| 2026-02-11 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Tax | 2,898 |
| 2026-02-11 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Other | 431,920 |
| 2026-01-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 |
| 2025-12-18 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,622 |
| 2025-12-12 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 |
| 2025-12-05 | TANNENBAUM RENEE P | Director | Sell | 1,800 |
| 2025-11-13 | Walsh Patrick D | Director | Sell | 8,643 |
| 2025-11-13 | Walsh Patrick D | Director | Gift | 3,000 |
| 2025-11-13 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Sell | 94 |
| 2025-11-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 |
| 2025-11-12 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Other | 73,615 |
| 2025-11-12 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Sell | 14,642 |
| 2025-10-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 |
| 2025-09-19 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,000 |
| 2025-09-12 | Davis Krista | SVP, CHIEF HR OFFICER | Tax | 1,710 |
| 2025-09-12 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 |
| 2025-09-03 | Pera Antonio R | Director | Sell | 7,292 |
| 2025-08-25 | Leonard Matthew J | Director | Sell | 2,528 |
| 2025-08-22 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,763 |
| 2025-08-21 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sell | 52,988 |
| 2025-08-20 | Pera Antonio R | Director | Sell | 5,421 |
| 2025-08-20 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sell | 47,012 |
| 2025-08-20 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Other | 92,588 |
| 2025-08-18 | Thoma Jeanne | Director | Sell | 6,865 |
| 2025-08-18 | Leonard Matthew J | Director | Sell | 6,937 |
| 2025-08-15 | Walsh Patrick D | Director | Sell | 9,000 |
| 2025-08-15 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sell | 52,990 |
| 2025-08-15 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Sell | 20,000 |
| 2025-08-15 | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Other | 73,615 |
| 2025-08-14 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sell | 47,010 |
| 2025-08-14 | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Other | 92,588 |
| 2025-08-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 |
| 2025-08-12 | CAREY STEPHEN P. | SVP & CFO | Convert | 50,000 |